Sichuan Kelun Pharmaceutical Co., Ltd. Class A
002422
Classement en actions
#2008
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and... Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Prix de l'action
$6.40
Capitalisation boursière
$10.19B
Changement (1 jour)
-0.77%
Changement (1 an)
27.14%
Pays
CN
Échange Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Catégorie
Healthcare
Revenus pour Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Revenus en Jun 2026 TTM : $2.74B
Selon les derniers rapports financiers de Sichuan Kelun Pharmaceutical Co., Ltd. Class A, le chiffre d'affaires actuel de l'entreprise (TTM) est de $2.74B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $2.99B une diminution par rapport à le chiffre d'affaires de l'année 2023, qui était de $3.03B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Sichuan Kelun Pharmaceutical Co., Ltd. Class A de 2007 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $2.74B | 4.30% |
| 2025 | $2.62B | -12.23% |
| 2024 | $2.99B | -1.40% |
| 2023 | $3.03B | 9.81% |
| 2022 | $2.76B | 1.53% |
| 2021 | $2.72B | 7.86% |
| 2020 | $2.52B | -0.49% |
| 2019 | $2.53B | 6.54% |
| 2018 | $2.38B | 35.26% |
| 2017 | $1.76B | 42.45% |
| 2016 | $1.23B | 3.20% |
| 2015 | $1.20B | -7.71% |
| 2014 | $1.30B | 15.02% |
| 2013 | $1.13B | 19.33% |
| 2012 | $943.78M | 16.57% |
| 2011 | $809.60M | 32.72% |
| 2010 | $610.02M | 29.33% |
| 2009 | $471.69M | 23.71% |
| 2008 | $381.28M | 38.09% |
| 2007 | $276.12M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $12.62B | 361.49% |
US
|
|
| $2.23B | -18.55% |
US
|
|
| $15.74B | 475.55% |
AU
|
|
| $10.11B | 269.61% |
BE
|
|
| $6.02B | 120.11% |
NL
|
